SUPERNUS PHARMACEUTICALS, INC. Accrued Income Taxes, Current
SUPERNUS PHARMACEUTICALS, INC. (SUPN) had Accrued Income Taxes, Current of $5.74 million as of 2021-03-31, per its 10-Q filed 2021-05-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current › Taxes Payable, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2021-05-07
- 2021-03-31: Accrued Income Taxes, Current $5.74M.
- 2020-12-31: Accrued Income Taxes, Current $0.00.
- 2020-09-30: Accrued Income Taxes, Current $0.00.
- 2020-06-30: Accrued Income Taxes, Current $25.05M.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2021-03-31 | $5.74M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $0.00 10-Q · filed 2021-05-07 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-06 |
| 2020-06-30 | $25.05M 10-Q · filed 2020-08-17 |
| 2020-03-31 | $9.10M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $2.44M 10-Q · filed 2020-11-06 |
| 2019-09-30 | $4.82M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $2.67M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $17.23M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $12.38M 10-K · filed 2020-02-28 |
| 2018-09-30 | $8.55M 10-Q · filed 2018-11-09 |
| 2018-03-31 | $16.27M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $15.94M 10-K · filed 2019-03-01 |
| 2017-09-30 | $6.49M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.61M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $1.68M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $7.00K 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |